Improved Survival With Adjuvant Cyclooxygenase 2 Inhibition in PIK3CA-Activated Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance).
Nowak JA, Twombly T, Ma C, Shi Q, Haruki K, Fujiyoshi K, Väyrynen J, Zhao M, Knight J, Mane S, Shergill A, Kumar P, Couture F, Kuebler P, Krishnamurthi S, Tan B, Philip P, O'Reilly EM, Shields AF, Ogino S, Fuchs CS, Meyerhardt JA.
Nowak JA, et al. Among authors: kumar p.
J Clin Oncol. 2024 Jun 18:JCO2301680. doi: 10.1200/JCO.23.01680. Online ahead of print.
J Clin Oncol. 2024.
PMID: 38889377